These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1442 related items for PubMed ID: 32028981

  • 1. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W, Luo Y, Zhou Y, Li M, Wu C, Duan Y, Wang H, Fan S, Li Z, Xiong W, Li X, Li G, Ren C, Li H, Zhou M.
    J Exp Clin Cancer Res; 2020 Feb 07; 39(1):30. PubMed ID: 32028981
    [Abstract] [Full Text] [Related]

  • 2. TRIM28 promotes tumor growth and metastasis in breast cancer by targeting the BRD7 protein for ubiquitination and degradation.
    Xue C, Meng H, Niu W, Li M, Wei J, Chen S, Zheng L, Duan Y, Deng H, Tang F, Fan S, Tan M, Xiong W, Zhou M.
    Cell Oncol (Dordr); 2024 Oct 07; 47(5):1973-1993. PubMed ID: 39222175
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Knockdown of lncRNA ZEB2NAT suppresses epithelial mesenchymal transition, metastasis and proliferation in breast cancer cells.
    Eroğlu Güneş C, Güçlü E, Vural H, Kurar E.
    Gene; 2021 Dec 30; 805():145904. PubMed ID: 34418470
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
    Wang X, Zhou X, Zeng F, Wu X, Li H.
    Breast Cancer; 2020 Jul 30; 27(4):765-775. PubMed ID: 32144736
    [Abstract] [Full Text] [Related]

  • 13. LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.
    Du X, Tu Y, Liu S, Zhao P, Bao Z, Li C, Li J, Pan M, Ji J.
    J Cell Mol Med; 2020 Jan 30; 24(2):1474-1487. PubMed ID: 31856394
    [Abstract] [Full Text] [Related]

  • 14. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y, Ma H, Gao C, Lv Y, Chen X, Xu R, Sun M, Liu X, Lu X, Pei X, Li P.
    J Transl Med; 2018 Feb 23; 16(1):38. PubMed ID: 29471858
    [Abstract] [Full Text] [Related]

  • 15. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
    Li J, Hao Y, Mao W, Xue X, Xu P, Liu L, Yuan J, Zhang D, Li N, Chen H, Zhao L, Sun Z, Luo J, Chen R, Zhao RC.
    J Hematol Oncol; 2019 Feb 22; 12(1):19. PubMed ID: 30795783
    [Abstract] [Full Text] [Related]

  • 16. High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer.
    Liao YM, Wang YH, Hung JT, Lin YJ, Huang YL, Liao GS, Hsu YL, Wu JC, Yu AL.
    Breast Cancer Res; 2021 Jan 07; 23(1):5. PubMed ID: 33413566
    [Abstract] [Full Text] [Related]

  • 17. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, Blick T, Toh A, Hill P, Gilles C, Waltham M, Thompson EW.
    Breast Cancer Res; 2017 Jul 27; 19(1):86. PubMed ID: 28750639
    [Abstract] [Full Text] [Related]

  • 18. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.
    Huo X, Li S, Shi T, Suo A, Ruan Z, Guo H, Yao Y.
    Oncotarget; 2015 Dec 08; 6(39):41959-75. PubMed ID: 26544623
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y, Xu W, Zhao W, Wang W, Zhang D, Wu P.
    Biomed Pharmacother; 2017 Feb 08; 86():426-433. PubMed ID: 28012397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.